Logan Coy Related postsRandomized, open-label study of the BRIA-IMT regimen and checkpoint inhibitor vs physician’s choice in advanced metastatic breast cancer (BRIA-ABC)September 10, 2026A Phase 3, randomised, double-blind, placebo-controlled, multicentre trial comparing trilaciclib versus placebo in limited-stage small cell lung cancerSeptember 11, 2026A Phase 1 Study of IM-1021 in Participants with Advanced MalignanciesSeptember 11, 2026 Previous postA Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the LungsNext postA Phase 1 Dose Escalation Study of the Tolerability, Safety, Efficacy and Pharmacokinetics of ZG006 in Small Cell Lung Cancer